In Vivo Dual CAR T Design Opens Tumor Vasculature

A peer-reviewed Nature Communications article published online November 19 reports an mRNA lipid nanoparticle system that programs two complementary CAR T populations in vivo: one targeting VEGFR2-positive tumor vasculature and one targeting a tumor…




